Studies of thymopoietin pentapeptide (TP5) on experimental tumors. I. TP5 relieves immunosuppression in tumor-bearing mice.
D000818:Animals; D005260:Female; D006728:Hormones / Q000627:therapeutic use; D007108:Immune Tolerance / Q000187:drug effects*; D007116:Immunization, Passive; D008175:Lung Neoplasms / Q000188:drug therapy; D012515:Mast-Cell Sarcoma / Q000188:drug therapy; D051379:Mice; D008815:Mice, Inbred Strains; D009374:Neoplasms, Experimental / Q000188:drug therapy* / Q000276:immunology; D010446:Peptide Fragments / Q000627:therapeutic use*; D012513:Sarcoma, Experimental / Q000188:drug therapy; D016305:Thymopentin; D013946:Thymopoietins / Q000627:therapeutic use*; D013951:Thymus Hormones / Q000627:therapeutic use*
D006728:Hormones; D010446:Peptide Fragments; D013946:Thymopoietins; D013951:Thymus Hormones; D016305:Thymopentin